MedPath

INSIGHTEC, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Bilateral Treatment of Medication Refractory Essential Tremor

Not Applicable
Active, not recruiting
Conditions
Essential Tremor
First Posted Date
2019-10-02
Last Posted Date
2025-05-01
Lead Sponsor
InSightec
Target Recruit Count
51
Registration Number
NCT04112381
Locations
🇺🇸

Stanford University, School of Medicine, Stanford, California, United States

🇺🇸

University of Maryland, Baltimore, Maryland, United States

🇺🇸

Weill Cornell Medicine, New York, New York, United States

and more 4 locations

Safety and Initial Effectiveness of Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease

Not Applicable
Conditions
Parkinson Disease
First Posted Date
2019-06-28
Last Posted Date
2019-06-28
Lead Sponsor
InSightec
Target Recruit Count
50
Registration Number
NCT04002596
Locations
🇨🇳

Henan Provincial Peoples Hospital, Zhengzhou, Henan, China

🇯🇵

Shonan Fujisawa Tokushukai Hospital, Fujisawa, Kanagawa, Japan

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

Not Applicable
Active, not recruiting
Conditions
Prostate Cancer
First Posted Date
2019-06-26
Last Posted Date
2025-05-01
Lead Sponsor
InSightec
Target Recruit Count
14
Registration Number
NCT03998657
Locations
🇺🇸

Stanford University School of Medicine, Stanford, California, United States

🇺🇸

Sperling Prostate Center, Delray Beach, Florida, United States

🇺🇸

Brigham & Women's Hospital, Boston, Massachusetts, United States

and more 2 locations

A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PD

Not Applicable
Conditions
Parkinson Disease
Neurologic Manifestations
First Posted Date
2019-05-28
Last Posted Date
2022-08-03
Lead Sponsor
InSightec
Target Recruit Count
3
Registration Number
NCT03964272
Locations
🇪🇸

Hospital Universitario HM Puerta Del Sur. CINAC, Móstoles, Madrid, Spain

Safety and Feasibility of ExAblate Neuro System to Perform Auto-Focusing Echo Imaging in Patients With Essential Tremor

Not Applicable
Conditions
Neurologic Manifestations
Tremor, Essential
Tremor
First Posted Date
2019-05-02
Last Posted Date
2021-09-17
Lead Sponsor
InSightec
Target Recruit Count
20
Registration Number
NCT03935581
Locations
🇨🇦

Sunnybrook, Toronto, Ontario, Canada

🇰🇷

Yonsei University Health System, Severance Hospital, Seoul, Seodaemun-gu, Korea, Republic of

ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease

Not Applicable
Recruiting
Conditions
Alzheimer Disease
First Posted Date
2018-11-14
Last Posted Date
2023-03-02
Lead Sponsor
InSightec
Target Recruit Count
30
Registration Number
NCT03739905
Locations
🇨🇦

Division of Neurosurgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases

Not Applicable
Conditions
Brain Metastases
Breast Cancer
First Posted Date
2018-10-22
Last Posted Date
2021-08-24
Lead Sponsor
InSightec
Target Recruit Count
10
Registration Number
NCT03714243
Locations
🇨🇦

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy

Not Applicable
Completed
Conditions
Glioblastoma Multiforme
First Posted Date
2018-10-19
Last Posted Date
2024-03-05
Lead Sponsor
InSightec
Target Recruit Count
9
Registration Number
NCT03712293
Locations
🇰🇷

Severance Hospital, Yonsei University Health System, Seoul, Seodaemun-gu, Korea, Republic of

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Not Applicable
Recruiting
Conditions
Alzheimer Disease
First Posted Date
2018-09-14
Last Posted Date
2025-06-04
Lead Sponsor
InSightec
Target Recruit Count
150
Registration Number
NCT03671889
Locations
🇺🇸

Delray Medical Center & Florida Atlantic University, Delray Beach, Florida, United States

🇺🇸

Broward Health Medical Center & The University of Florida, Fort Lauderdale, Florida, United States

🇺🇸

University of Florida Health Shands, Gainesville, Florida, United States

and more 7 locations

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma

Not Applicable
Completed
Conditions
Glioblastoma
First Posted Date
2018-08-06
Last Posted Date
2024-01-23
Lead Sponsor
InSightec
Target Recruit Count
14
Registration Number
NCT03616860
Locations
🇨🇦

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy